View source for Chemistry:Enokizumab

{{Proposed deletion/dated
  |concern = nothing on PubMed
  |timestamp = 20181022042758
  |help = 
}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 450064744
| type = mab
| image = 
| alt = 
| mab_type = mab
| source = zu/o
| target = IL9
| tradename = 
| Drugs.com         =
| MedlinePlus       =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category=  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled -->
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = 
| routes_of_administration = 
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 
| ATC_prefix = none
| ATC_suffix = 
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = I4BE5F78HR
| PubChem = 
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank          =
| KEGG = D09897
| C=6492 | H=10000 | N=1704 | O=2038 | S=44
| molecular_weight = 148.4 kg/mol
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
}}

'''Enokizumab''' is a humanized monoclonal antibody designed for the treatment of [[Medicine:Asthma|asthma]].<ref>{{cite web|title=Statement On A Nonproprietary Name Adopted By The USAN Council: Enokizumab|publisher=American Medical Association|url=http://www.ama-assn.org/resources/doc/usan/enokizumab.pdf}}</ref>

Enokizumab was developed by [[Company:MedImmune|MedImmune]].

== References ==
<references/>

{{Monoclonals for immune system}}

[[Category:Monoclonal antibodies]]



{{Sourceattribution|Enokizumab|1}}